Jonathan Al-Saadi

Jonathan Al-Saadi

Auto-generated profile, based on publicly available information

Jonathan Al-Saadi

Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2020 in Radiology
Verified
Journal Article
Closed access
SKStefanos Klironomos
Stefanos Klironomos
ATAntonios Tzortzakakis
Antonios Tzortzakakis
AKAnnika Kits
Annika Kits
CÖClaes Öhberg
Claes Öhberg
EKEvangelia Kollia
Evangelia Kollia
TGTobias Granberg
Tobias Granberg
Background Neurological complications in coronavirus disease 2019 (COVID-19) have been described, but the understanding of their pathophysiology and neuroanatomical correlates remains limited. Purp...

27 February 2020 in Expert Review of Clinical Pharmacology
Verified
Journal Article
Open access
JPJoseph V. Pergolizzi
Joseph V. Pergolizzi
FCFlaminia Coluzzi
Flaminia Coluzzi
RCRobert D. Colucci
Robert D. Colucci
HOHanna Olsson
Hanna Olsson
JLJo Ann LeQuang
Jo Ann LeQuang
PMPeter Magnusson
Peter Magnusson
Introduction: Statins remain among the most frequently prescribed drugs and constitute a cornerstone in the prevention of cardiovascular disease. However, muscle symptoms are often reported from patients on statins. Muscle symptoms are frequently reported as adverse events associated with statin therapy. Areas covered: In the present narrative review, statin-associated muscle pain is discussed. It elucidates potential mechanisms and possible targets for management. Expert opinion: In general, the evidence in support of muscle pain caused by statins is in some cases equivocal and not particularly strong. Reported symptoms are difficult to quantify. Rarely is it possible to establish a causal link between statins and muscle pain. In randomized controlled trials, statins are well tolerated, and muscle-pain related side-effects is similar to placebo. There are also nocebo effects of statins. Exchange of statin may be beneficial although all statins have been associated with muscle pain. In some patients reduction of dose is worth trying, especially in primary prevention Although the benefits of statins outweigh potential risks in the vast majority of cases, careful clinical judgment may be necessary in certain cases to manage potential side effects on an individual basis.

24 January 2023 in Anatomical Sciences Education
Verified
Journal Article
Open access
APAnna Frideborg Pettersson
Anna Frideborg Pettersson
KKKlas Karlgren
Klas Karlgren
JAJonathan Al‐Saadi
Jonathan Al‐Saadi
HHHans Hjelmqvist
Hans Hjelmqvist
BMBjörn Meister
Björn Meister
CSCharlotte Silén
Charlotte Silén
Learning anatomy holds specific challenges, like the appreciation of three‐dimensional relationships between anatomical structures. So far, there is limited knowledge about how students construct their understanding of topographic anatomy. By understanding the processes by which students learn anatomical structures in 3D, educators will be better equipped to offer support and create successful learning situations. Using video analysis, this study investigates how students discern anatomical structures. Sixteen students at different levels of education and from different study programs were recorded audiovisually while exploring 3D digital images using a computerized visualization table. Eleven hours of recorded material were analyzed using interaction analysis and phenomenography. Seven categories were identified during data analysis, describing the qualitatively different patterns of actions that students use to make sense of anatomy: decoding the image; positioning the body in space; purposeful seeking, using knowledge and experience; making use of and creating variation; aimless exploration, and arriving at moments of understanding. The results suggest that anatomy instruction should be organized to let the students decide how and at what pace they examine visualized images. Particularly, the discovery process of decoding and positioning the body in space supports a deep learning approach for learning anatomy using visualizations. The students' activities should be facilitated and not directed.

11 March 2024 in Neuroradiology
Verified
Journal Article
Open access
PDF file
AKAnnika Kits
Annika Kits
JAJonathan Al-Saadi
Jonathan Al-Saadi
FLFrancesca De Luca
Francesca De Luca
FJFredrik Janzon
Fredrik Janzon
MMMichael V Mazya
Michael V Mazya
ADAnna Falk Delgado
Anna Falk Delgado
Purpose: To assess the performance of a 2.5-minute multi-contrast brain MRI sequence (NeuroMix) in diagnosing acute cerebral infarctions. Methods: Adult patients with a clinical suspicion of acute ischemic stroke were retrospectively included. Brain MRI at 3 T included NeuroMix and routine clinical MRI (cMRI) sequences, with DWI/ADC, T2-FLAIR, T2-weighted, T2*, SWI-EPI, and T1-weighted contrasts. Three radiologists (R1–3) independently assessed NeuroMix and cMRI for the presence of acute infarcts (DWI ↑, ADC = or ↓) and infarct-associated abnormalities on other image contrasts. Sensitivity, specificity, and the area under the receiver operating characteristic curve (AUC) were calculated and compared using DeLong’s test. Inter- and intra-rater agreements were studied with kappa statistics. Relative DWI (rDWI) and T2-FLAIR (rT2-FLAIR) signal intensity for infarctions were semi-automatically rendered, and the correlation between methods was evaluated. Results: According to the reference standard, acute infarction was present in 34 out of 44 (77%) patients (63 ± 17 years, 31 men). Other infarct-associated signal abnormalities were reported in similar frequencies on NeuroMix and cMRI (p > .08). Sensitivity for infarction detection was 94%, 100%, and 94% evaluated by R1, R2, R3, for NeuroMix and 94%, 100%, and 100% for cMRI. Specificity was 100%, 90%, and 100% for NeuroMix and 100%, 100%, and 100% for cMRI. AUC for NeuroMix was .97, .95, and .97 and .97, 1, and 1 for cMRI (DeLong p = 1, .32, .15), respectively. Inter- and intra-rater agreement was κ = .88–1. The correlation between NeuroMix and cMRI was R = .73 for rDWI and R = .83 for rT2-FLAIR. Conclusion: Fast multi-contrast MRI NeuroMix has high diagnostic performance for detecting acute cerebral infarctions.

11 December 2019 in Cureus
Verified
Journal Article
Open access
PDF file
HOHanna Olsson
Hanna Olsson
JAJonathan Al-Saadi
Jonathan Al-Saadi
DODaniel Oehler
Daniel Oehler
Joseph pergolizziJoseph pergolizzi
Joseph pergolizzi
PMPeter Magnusson
Peter Magnusson
Dietary supplementation with beetroot juice (BRJ), a naturally rich source of nitrate, is an area of considerable interest to elite athletes as well as recreational exercisers. Nitrate and nitrite have previously been thought of as mainly final elimination products of nitric oxide (NO), but this view has been challenged and evidence indicates that these compounds can be converted to NO in vivo. We conducted a narrative review summarizing the literature regarding evidence of beetroot used as dietary supplement and its effects on training physiology and athletic performance in healthy and diseased populations. The databases PubMed and Web of Science were used to obtain articles. It was evident that BRJ supplementation had an effect on oxygen cost and consumption during exercise by more efficient adenosine triphosphate (ATP) production in combination with lower ATP consumption. However, the effect seems to be dependent on dose and duration. Effect on exercise performance is conflicting, time to exhaustion seems to increase but its effect on time-trial performance needs further elucidation. Ergogenic benefits might depend on individual aerobic fitness level, where individuals with lower fitness level may gain higher benefits regarding athletic performance. Dietary nitrate supplementation appears to have some effect on training performance in patients with peripheral artery disease, heart failure, and chronic pulmonary obstructive disease. However, larger randomized controlled trials are necessary to determine the overall utility of beetroot as a dietary supplement.

27 February 2024 in Molecular Therapy - Methods & Clinical Development
Verified
Journal Article
Open access
JAJonathan Al-Saadi
Jonathan Al-Saadi
MWMathias Waldén
Mathias Waldén
MSMikael Sandell
Mikael Sandell
JSJesper Sohlmér
Jesper Sohlmér
RGRikard Grankvist
Rikard Grankvist
SHStaffan Holmin
Staffan Holmin
Heart failure has a poor prognosis and no curative treatment exists. Clinical trials are investigating gene- and cell-based therapies to improve cardiac function. The safe and efficient delivery of these therapies to solid organs is challenging. Herein, we demonstrate the feasibility of using an endovascular intramyocardial delivery approach to safely administer mRNA drug products and perform cell transplantation procedures in swine. Using a trans-vessel wall (TW) device, we delivered chemically modified mRNAs (modRNA) and mRNA-enhanced mesenchymal stromal cells expressing vascular endothelial growth factor A (VEGF-A) directly to the heart. We monitored and mapped the cellular distribution, protein expression, and safety tolerability of such an approach. The delivery of modRNA-enhanced cells via the TW device with different flow rates and cell concentrations marginally affect cell viability and protein expression in situ. Implanted cells were found within the myocardium for at least 3 days following administration, without the use of immunomodulation and minimal impact on tissue integrity. Finally, we could increase the protein expression of VEGF-A over 500-fold in the heart using a cell-mediated modRNA delivery system compared with modRNA delivered in saline solution. Ultimately, this method paves the way for future research to pioneer new treatments for cardiac disease.